MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2016 International Congress

    Negative emotional signals impair isometric force control in Parkinson’s disease

    R.L. Blakemore, M.R. MacAskill, R. Shoorangiz, T.J. Anderson (Christchurch, New Zealand)

    Objective: To investigate the effect of sustained exposure to negative emotional stimuli on isometric grip-force control in Parkinson's disease (PD). Background: Recent animal studies have…
  • 2016 International Congress

    Cortical excitability in patients with Parkinson’s disease on levodopa carbidopa intestinal gel thereapy

    S.D. Kim, S. Vucic, N. Mahant, M.C. Kiernan, V.S.C. Fung (Sydney, Australia)

    Objective: To assess whether there are changes in short interval intracortical inhibition (SICI) that reflect changes in motor function and plasma levodopa levels in patients…
  • 2016 International Congress

    The clinical significance of brain microbleed in Alzheimer’s disease patients with Parkinsonian signs

    J.Y. Ahn, H.T. Kim (Seoul, Korea)

    Objective: We investigated the clinical significance of brain microbleeds in Alzheimer's disease patients with MPS comparing patients without MPS. Background: Microbleeds(MBs) were observed frequently in…
  • 2016 International Congress

    Analysis of cognitive disorders of Parkinson’s disease (PD) in the comparative aspect

    S. Lukmonov, D. Tolibov, A. Sobirov, F. Yunusov, D. Jalilov, K. Abdukhalimova, A. Kalendarev (Tashkent, Uzbekistan)

    Objective: Purpose of investigation was to conduct a comparative assessment of cognitive impairment in Parkinson's disease. Background: According to modern concepts, parkinsonism - is not…
  • 2016 International Congress

    Gait and cognition: Mapping the global and discrete relationships in ageing and neurodegenerative disease

    R. Morris, S. Lord, J. Bunce, D. Burn, L. Rochester (Newcastle-Upon-Tyne, United Kingdom)

    Objective: To explore current evidence of associations and predictors of gait and cognition in older adults and pathology to provide a clear understanding of current…
  • 2016 International Congress

    The effects of deep brain stimulation for Parkinson’s disease on cognition and perceived quality of life: Preliminary results from an Ecuadorian sample

    M.B. Jurado Noboa, R. Santibañez Vásquez, J. Achi, M. Navarrete, C. Mawyin (Guayaquil, Ecuador)

    Objective: To evaluate the effects of deep brain stimulation (DBS) on cognition and perceived quality of life in the first cohort of patients undergoing DBS…
  • 2016 International Congress

    Analysis of factors associated with cognitive and functional performance in Parkinsonian with normal mini-mental state examination

    R. Breder, M.A.A. Leite, M.C.A. Ribas, M. Orsini (Niterói, Brazil)

    Objective: To evaluate the correlation between cognitive and functional performance of Parkinsonian with normal Mini-Mental State Examination (MMSE), and demographic variables, motor impairment, neuropsychiatric disorders…
  • 2016 International Congress

    Unilateral subthalamotomy in Parkinson´s disease: Cognitive and neuropsychiatric effects and correlation with lesion size

    I. Obeso, E. Casabona, R. Rodríguez-Rojas, N. Pavón, R. Macías, M.L. Bringas, J.A. Obeso, M. Jahanshahi (Madrid, Spain)

    Objective: To assess cognitive and neuropsychiatric effects of unilateral subthalamotomy in Parkinson´s disease (PD) and their correlation with lesion size. Background: Surgery for treatment of…
  • 2016 International Congress

    The effect of statin use on cognition in Parkinson’s disease

    B.L. Deck, J. Rick, S.X. Xie, A. Chen-Plotkin, J.E. Duda, J.F. Morley, L.M. Chahine, N. Dahodwala, R.S. Akhtar, J.Q. Trojanowski, D. Weintraub (Philadelphia, PA, USA)

    Objective: To evaluate the effect of statin (HMG CoA reductase inhibitor) use on 1) baseline cognition; 2) rate of cognitive decline; and 3) conversion from…
  • 2016 International Congress

    Apraxia in Parkinson’s disease

    M. Tábuas-Pereira, P. Correia, F. Moreira, A. Morgadinho, C. Januário (Coimbra, Portugal)

    Objective: We aim to study apraxia in Parkinson's disease. Background: Limb apraxia is a cognitive motor disorder of skilled, purposive movements not caused by elementary…
  • « Previous Page
  • 1
  • …
  • 183
  • 184
  • 185
  • 186
  • 187
  • …
  • 207
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • An atypical and interesting feature of Parkinson´s disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Clinical Associations of Hand Deformities in Parkinson´s Disease
  • Crack Dancing: An Uncommon Drug-Induced Chorea
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley